BioVie Inc.


Symbol has changed to a new ticker symbol


By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


BioVie Inc is active in the healthcare domain in the United States. The company is a development stage enterprise engaged in the discovery, development, and commercialization of a therapy targeting ascites due to liver cirrhosis. Its therapy BIV201 is based on a drug that is approved in about 40 countries to treat related complications of liver cirrhosis. BioVie is developing BIV201 for alleviating the portal hypertension and correcting splanchnic vasodilation, thereby increasing effective blood volume and reducing the signals to the kidneys to retain excess salt and water.

Contact Information

Main Phone: +1 312 283-5793
Address: 2120 Colorado Avenue
Address 2: Suite 230
State: CA
City / Town: Santa Monica
Country: US
Postal Code: 90404

Issuer Information

Exchange: NSC
CEO: Terren S. Peizer
Employees: 4
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A